# 02_KNOWLEDGE_PASSPORT --- PP-0178 Histopathologic Classification

## Identity

-   **KP ID:** KP-PP-0178
-   **PP ID:** PP-0178
-   **Title:** Histopathologic Classification
-   **Version:** 1.0.0
-   **Status:** GOLD --- READY FOR INTEGRATION
-   **Last Updated:** 2026-08-09

## Knowledge Classification

-   **Clinical Domain:** Diagnosis / Pathology
-   **Primary Knowledge Type:** Patient-facing clinical education
-   **Secondary Knowledge Types:** Diagnostic pathology, histologic
    classification, specimen-specific pathology
-   **Clinical Complexity:** Intermediate
-   **Educational Level:** Foundational-to-intermediate
-   **Atomic Clinical Question:** How is gastric cancer characterized
    under the microscope, and what do the main histopathologic terms
    mean?
-   **Primary Runtime Intent:** Explain and contextualize gastric-cancer
    histopathology after biopsy or resection.
-   **Primary Clinical Dependency:** Adequate tissue acquisition and
    pathology review.
-   **Primary Downstream Dependencies:** Lauren classification,
    molecular classification, biomarker testing and staging.

## Patient Journey Classification

-   **Journey Stage:** Diagnosis → Pathology characterization → Staging
    / molecular characterization
-   **Primary Patient Question:** "What does the pathology examination
    of my gastric tissue tell us?"
-   **Secondary Patient Questions:**
    -   "What does intestinal or diffuse type mean?"
    -   "What does poorly differentiated mean?"
    -   "Why does my resection report contain more information than my
        biopsy?"
    -   "Is histology the same as stage?"
    -   "Why are additional biomarker tests needed?"

## Intended Runtime Usage

This package is intended to:

1.  Explain histopathology after tissue acquisition.
2.  Translate common histologic terminology into patient-understandable
    concepts.
3.  Prevent conflation of histologic type, grade, invasion and stage.
4.  Explain why pathology detail differs by specimen type.
5.  Prepare the reader for specialized Lauren, molecular and biomarker
    packages.
6.  Support interpretation of pathology-related questions without
    providing individualized diagnosis or treatment advice.

## Retrieval / Runtime Relevance

### High-Priority Retrieval Concepts

-   gastric adenocarcinoma histology
-   histopathologic classification
-   intestinal type
-   diffuse type
-   signet-ring cells
-   poorly cohesive carcinoma
-   tumor grade
-   histologic differentiation
-   invasion
-   lymphovascular invasion
-   margins
-   gastric pathology
-   biopsy pathology
-   EMR pathology
-   gastrectomy pathology
-   Lauren classification
-   molecular classification
-   pathology and biomarkers

### Query Expansion Terms

-   gastric cancer histologic type
-   gastric adenocarcinoma morphology
-   intestinal gastric adenocarcinoma
-   diffuse gastric adenocarcinoma
-   signet ring cell carcinoma
-   poorly differentiated gastric cancer
-   pathologic review gastric cancer
-   gastric cancer pathology report
-   gastric cancer grade
-   gastric cancer invasion
-   gastric cancer resection pathology

## Knowledge Graph

### Prerequisites

-   PP-0175 --- Gastric Cancer Diagnostic Work-up
-   PP-0176 --- Endoscopic Diagnosis of Gastric Cancer
-   PP-0177 --- Endoscopic Biopsy Strategy
-   Foundational pathology-report literacy packages

### Related

-   PP-0168 --- EBV-associated Gastric Cancer + EBV Testing
-   PP-0169 --- Gastric Adenomas and Cancer Risk
-   PP-0159 --- HDGC Endoscopic Surveillance
-   TNM staging packages
-   Pathology-report literacy packages

### Downstream

-   PP-0179 --- Lauren Classification
-   PP-0180 --- Gastric Cancer Molecular Classification
-   PP-0181 --- HER2 Testing
-   PP-0182 --- MSI/MMR Testing
-   PP-0183 --- PD-L1 Testing
-   PP-0184 --- CLDN18.2 Testing
-   PP-0185 --- TMB
-   PP-0186 --- FGFR2 Testing
-   PP-0187 --- NGS Biomarker Testing
-   PP-0189 --- Genomic Test Results / How to Read a Molecular Report
-   PP-0190--PP-0191 --- Biomarker-guided Treatment

## Clinical Scope

### Core Knowledge Ownership

PP-0178 owns the pathology characterization layer between tissue
acquisition and downstream specialized classification/testing.

The package owns:

-   histopathology as a concept;
-   microscopic recognition of gastric adenocarcinoma;
-   major intestinal/diffuse patterns;
-   selected morphologic forms;
-   grade/differentiation concepts;
-   invasion;
-   specimen-specific pathology;
-   pathology interfaces with staging, Lauren, molecular classification
    and biomarkers.

### Supporting Knowledge

-   dysplasia versus invasive carcinoma;
-   treatment effect in selected post-treatment specimens;
-   lymph-node pathology as a staging interface;
-   clinical-pathologic discordance;
-   pathology review;
-   histologic heterogeneity;
-   patient-facing terminology.

### Explicit Exclusions

The package does not own:

-   endoscopic diagnosis;
-   biopsy technique;
-   complete staging;
-   detailed Lauren classification;
-   exhaustive WHO taxonomy;
-   molecular classification;
-   individual biomarker testing;
-   NGS methodology;
-   genomic report interpretation;
-   endoscopic resection technique;
-   hereditary surveillance;
-   precursor-lesion management;
-   individualized prognosis;
-   individualized treatment.

## Authoritative Sources

### Primary

1.  NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer,
    Version 2.2026.
2.  NCI PDQ materials on gastric cancer and gastric cancer
    screening/treatment where they directly describe histologic
    patterns.
3.  NCI Hereditary Diffuse Gastric Cancer / Genetics of Gastric Cancer
    PDQ where directly relevant to signet-ring and diffuse morphology.
4.  ESMO--ASCO Recommendations for a Global Curriculum in Medical
    Oncology, 2023, pathology section.

### Supporting

-   Current project Registry and Governance documents.
-   Approved PP Discussion depth/format reference.
-   Adjacent approved PP packages as structural references only.

## Evidence Classification

  -----------------------------------------------------------------------
  Knowledge Area          Evidence Class          Primary Support
  ----------------------- ----------------------- -----------------------
  Histologic type         Established             NCCN

  Intestinal/diffuse      Established             NCCN, NCI
  patterns                                        

  Tubular/glandular       Established             NCCN, NCI
  architecture                                    

  Signet-ring morphology  Established             NCCN, NCI HDGC PDQ

  Grade                   Established             NCCN

  Invasion                Established             NCCN

  EMR pathology elements  Established             NCCN

  Gastrectomy pathology   Established             NCCN
  elements                                        

  Treatment-effect        Established in          NCCN
  assessment              specified context       

  Clinical-pathologic     Established oncology    ESMO--ASCO
  discordance             pathology competency    

  Lauren relationship     Established conceptual  NCI/NCCN + Registry
                          interface               

  Molecular               Conceptual interface    ESMO--ASCO + Registry
  classification                                  
  relationship                                    

  Biomarker interface     Established             NCCN

  Individual prognosis    Not owned               Out of scope
  from histology                                  

  Individual treatment    Not owned               Out of scope
  recommendation                                  
  -----------------------------------------------------------------------

## Governance Metadata

-   **Execution Rule:** User-controlled PP sequence.
-   **Source Rule:** Source-first.
-   **Clinical Content Rule:** Source-grounded; do not fill unsupported
    gaps with unverified assumptions.
-   **Artifact Rule:** Four governed artifacts.
-   **Depth Rule:** Absolute full-depth compliance; no compacting or
    shortening relative to approved Gold references.
-   **Boundary Rule:** One clean four-part Boundary in final production
    response.
-   **QA Rule:** Four-layer QA.
-   **Repository Readiness:** Ready for integration after final QA.

## Version Control

-   **Semantic Version:** 1.0.0
-   **Status:** Gold
-   **Change Type:** Initial production from locked Decision Batch.
-   **Supersedes:** None within this PP.
-   **Source Version Context:** NCCN Gastric Cancer Version 2.2026;
    ESMO--ASCO 2023; current NCI PDQ materials available in Source
    Files.

## Change History

  -----------------------------------------------------------------------
  Version                 Date                    Change
  ----------------------- ----------------------- -----------------------
  1.0.0                   2026-08-09              Initial Gold Population
                                                  Package generated after
                                                  PP-0178 scope
                                                  approval/lock.

  -----------------------------------------------------------------------

## Final Status

**GOLD --- READY FOR INTEGRATION**

The Knowledge Passport is structurally complete and aligned with the
locked Gold Population Package specification.
